Stock Fundamentals

Company Information

Company Name
Tempest Therapeutics Inc
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
ISIN: US87978U1088
CIK: 0001544227
CUSIP: 87978U108
Currency: USD
Full Time Employees: 4
Phone: 415 798 8589
Fiscal Year End: December
IPO Date: Nov 12, 2012
Description:

Tempest Therapeutics, Inc., a clinical-stage biotechnology company, develops small molecule therapeutics to treat cancer. Its lead product candidates include Amezalpat, an oral small molecule selective antagonist of peroxisome proliferator-activated receptor alpha for the treatment of first-line unresectable or metastatic hepatocellular carcinoma that completed Phase 2 clinical trial; and TPST-1495, a small-molecule dual antagonist of the EP2 and EP4 receptors of prostaglandin E2 for treating various cancers. The company has a collaboration agreement with F. Hoffmann-La Roche Ltd. for the development of Amezalpat into a global first-line randomized study. Tempest Therapeutics, Inc. is headquartered in Brisbane, California.

Address:

2000 Sierra Point Parkway, Brisbane, CA, United States, 94005

Directors & Officers

Name Title Year Born
Mr. Nicholas Maestas CFO, Head of Corporate Strategy & Secretary 1981
Dr. Matthew Angel Ph.D. President, CEO & Director 1982
Mr. Justin Trojanowski CPA Corporate Controller, Treasurer & Principal Accounting Officer 1989
Dr. Andrew Fang Ph.D. Head of Business Development NA

Insider Trading

Date Insider Name Title Transaction Type Shares Price Value
Mar 24, 2026 Matthew Angel N/A Purchase 231.48K $2.16 $500.00K

Institutional Holders

Holder Name Shares Date Reported % Out Value % Change
Vanguard Group Inc 162.56K Dec 31, 2025 1.13% $0.00 0.00%
Geode Capital Management, LLC 86.99K Mar 31, 2026 0.61% $0.00 97.20%
BlackRock Inc 39.07K Mar 31, 2026 0.27% $0.00 0.00%
FMR Inc 33.23K Mar 31, 2026 0.23% $0.00 0.00%
Sabby Management LLC 17.86K Mar 31, 2026 0.12% $0.07 -90.00%
Northern Trust Corp 14.05K Mar 31, 2026 0.10% $0.00 0.00%
Dimensional Fund Advisors, Inc. 11.44K Mar 31, 2026 0.08% $0.00 0.00%
UBS Group AG 4.53K Mar 31, 2026 0.03% $0.00 -74.16%
Tower Research Capital LLC 2.79K Mar 31, 2026 0.02% $0.00 110.57%
Morgan Stanley - Brokerage Accounts 2.06K Mar 31, 2026 0.01% $0.00 0.00%
Advisor Group Holdings, Inc. 1.53K Mar 31, 2026 0.01% $0.00 -5.21%
Atlantic Trust Group, LLC 1.08K Dec 31, 2025 0.01% $0.00 134.78%
Federation des caisses Desjardins du Quebec 292.00 Mar 31, 2026 0.00% $0.00 0.00%
JONES FINANCIAL COMPANIES LLLP 239.00 Mar 31, 2026 0.00% $0.00 0.00%
SBI Securities Co Ltd 56.00 Mar 31, 2026 0.00% $0.00 0.00%
Royal Bank of Canada 27.00 Mar 31, 2026 0.00% $0.00 237.50%
Parallel Advisors, LLC 18.00 Mar 31, 2026 0.00% $0.00 0.00%
Citigroup Inc 8.00 Mar 31, 2026 0.00% $0.00 0.00%
JPMorgan Chase & Co 5.00 Mar 31, 2026 0.00% $0.00 0.00%
BNP Paribas Arbitrage, SA 3.00 Mar 31, 2026 0.00% $0.00 0.00%

Shares Statistics

Shares Outstanding: 14.81M
Shares Float: 9.27M
% Insiders: 3,426.40%
% Institutions: 2,848.90%
Short % Float: 6.85%

Fund Holdings

Rank Holder Name Shares Held % of Shares Change Date Reported
1 Vanguard Institutional Extnd Mkt Idx Tr 128.94K 0.90% ▲ 0.00% Apr 30, 2026
2 Vanguard Total Stock Mkt Idx Inv 104.94K 0.73% ▲ 0.00% Apr 30, 2026
3 Fidelity Extended Market Index 60.30K 0.42% ▲ 147.94% Mar 31, 2026
4 Abante Quant Value FI 41.82K 0.29% ▲ 0.00% Mar 31, 2026
5 Spartan Extended Market Index Pool F 12.07K 0.08% ▲ 137.62% Mar 31, 2026
6 NT Ext Equity Mkt Index Fund - Lending 10.94K 0.08% ▲ 0.00% Mar 31, 2026
7 Northern Trust Extended Eq Market Idx 10.94K 0.08% ▲ 141.38% Mar 31, 2026
8 Fidelity Total Market Index 7.50K 0.05% ▲ 0.00% Mar 31, 2026
9 Fidelity Series Total Market Index 4.42K 0.03% ▲ 0.00% Mar 31, 2026
10 NT Ext Eq Mkt Idx Fd DC Lending Tier 5 4.32K 0.03% ▲ 0.70% Mar 31, 2026

Valuation Metrics

Enterprise Value: $27.74M
Trailing P/E: 0.00
Forward P/E: 0.00

Financial Highlights

Market Cap: $19.40M
EBITDA: $-26.31M
Book Value: $1.35
Earnings/Share: $-5.70
Profit Margin: 0.00%
Operating Margin: 0.00%
ROA (TTM): -56.86%
ROE (TTM): -203.63%
Revenue (TTM): $0.00
Revenue/Share (TTM): $0.00
Earnings Growth (YOY): 0.00%
Revenue Growth (YOY): 0.00%

Stock Price History

1 Year Price History

2 Years Price History

5 Years Price History

10 Years Price History

Financial Charts

Revenue & Net Income (Yearly)

Revenue & Net Income (Quarterly)

Operating Expenses (Yearly)

Operating Expenses (Quarterly)

Balance Sheet (Yearly)

Balance Sheet (Quarterly)

Assets Breakdown (Yearly)

Assets Breakdown (Quarterly)

Liabilities Breakdown (Yearly)

Liabilities Breakdown (Quarterly)

Earnings Per Share (EPS) History

Financial Ratios

Balance Sheet (Yearly)

Financial Ratios

Date Current Ratio Debt/Equity Debt/Assets Interest Coverage Debt/EBITDA
2025-12-31 2.50x 0.18x 0.61x -128.38x -0.05x
2024-12-31 2.21x 0.38x 0.54x -31.93x -0.18x
2023-12-31 4.29x 0.43x 0.48x -20.12x -0.42x
2022-12-31 4.53x 0.65x 0.61x -21.41x -0.35x
2021-12-31 3.44x 0.46x 0.51x -21.05x -0.62x
2020-12-31 6.15x -0.01x 4.01x -38.06x -0.04x
2019-12-31 5.68x 0.03x 0.20x -43.74x -0.05x
2018-12-31 8.50x 0.00x 0.13x -172.51x -0.01x
2017-12-31 4.82x 0.08x 0.24x N/A 0.00x
2016-12-31 8.82x 0.00x 0.12x -122.93x 0.00x
2015-12-31 11.55x 0.00x 0.08x -165.14x 0.00x
2014-12-31 6.08x 0.00x 0.16x N/A 0.00x
2013-12-31 7.81x 0.00x 0.12x N/A 0.00x
2012-12-31 15.32x 0.00x 0.06x N/A 0.00x
2011-12-31 6.79x 0.00x 0.17x N/A 0.00x

📦 Raw API Data (JSON Explorer)

Watchlist

0

No stocks in watchlist

Assistant

×
Hello! I'm your AI assistant. I have access to the financial data on this page. Ask me anything about TPST.US!